Qi L. Yang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

RAR and infant mortality: a crucial link in cardiac surgery outcomes.

RAR and infant mortality: a crucial link in cardiac surgery outcomes.

Journal: Frontiers in immunology
Published: February 07, 2026

Transplantation of Mitochondria isolated from iPSC-MSCs mitigates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescence.

Transplantation of Mitochondria isolated from iPSC-MSCs mitigates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescence.

Journal: Free radical biology & medicine
Published: November 25, 2025

Targeting the host factor HGS-viral membrane protein interaction in coronavirus infection.

Targeting the host factor HGS-viral membrane protein interaction in coronavirus infection.

Journal: The Journal of clinical investigation
Published: September 15, 2025

Elucidation of anti-SARS-CoV-2 and anti-inflammatory bioactives in Qingyan Dropping Pills via integrated in silico screening and bioactivity validation.

Elucidation of anti-SARS-CoV-2 and anti-inflammatory bioactives in Qingyan Dropping Pills via integrated in silico screening and bioactivity validation.

Journal: Frontiers in medicine
Published: August 13, 2025

Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes.

Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes.

Journal: Journal of virology
Published: April 25, 2025

A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro.

A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro.

Journal: Nature communications
Published: March 04, 2025

Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation.

Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation.

Journal: Acta pharmaceutica Sinica. B
Published: March 01, 2025

Expanding the utilization of binding pockets proves to be effective for noncovalent small molecule inhibitors against SARS-CoV-2 Mpro.

Expanding the utilization of binding pockets proves to be effective for noncovalent small molecule inhibitors against SARS-CoV-2 Mpro.

Journal: European journal of medicinal chemistry
Published: February 05, 2025

MA104 cell line is permissive for human bocavirus 1 infection.

MA104 cell line is permissive for human bocavirus 1 infection.

Journal: Journal of virology
Published: January 23, 2025

Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19.

Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19.

Journal: Nature communications
Published: January 21, 2025

The crystal structure of coronavirus RBD-TMPRSS2 complex provides basis for the discovery of therapeutic antibodies.

The crystal structure of coronavirus RBD-TMPRSS2 complex provides basis for the discovery of therapeutic antibodies.

Journal: Nature communications
Published: October 19, 2024

High-throughput screening of dual-target inhibitors for SARS-CoV-2 main protease and papain-like protease from Chebulae Fructus: in silico prediction and experimental verification.

High-throughput screening of dual-target inhibitors for SARS-CoV-2 main protease and papain-like protease from Chebulae Fructus: in silico prediction and experimental verification.

Journal: Frontiers in microbiology
Published: October 13, 2024
Showing 1-12 of 31

Last Updated: 09/26/2026